Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950129-06-001307
Filing Date
2006-02-10
Accepted
2006-02-10 17:06:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMVESCAP PLC FOR PDL BIOPHARMA INC. h32691g7sc13gza.txt SC 13G/A 11459
  Complete submission text file 0000950129-06-001307.txt   13811
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 06599566
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG
Business Address 30 FINSBURY SQUARE LONDON EC2A 1AG ENGLAND X0 EC2A 1AG 442076380731
AMVESCAP PLC/LONDON/ (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice